{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:14:57Z","timestamp":1791216897644,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1208\/s12248-009-9093-4","type":"journal-article","created":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T15:12:49Z","timestamp":1236611569000},"page":"148-154","source":"Crossref","is-referenced-by-count":42,"title":["Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making"],"prefix":"10.1208","volume":"11","author":[{"given":"Kristin C.","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radojka M.","family":"Savi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"9093_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2165\/00003088-199936040-00001","volume":"36","author":"L. Aarons","year":"1999","unstructured":"L. Aarons. Software for population pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet.\n                  36:255\u2013264 (1999).","journal-title":"Clin. Pharmacokinet."},{"key":"9093_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1023\/A:1014857832337","volume":"16","author":"S. Sadray","year":"1999","unstructured":"S. Sadray, E. N. Jonsson, and M. O. Karlsson. Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection. Pharm Res.\n                  16:1260\u20131265 (1999).","journal-title":"Pharm Res."},{"key":"9093_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.0306-5251.2003.01850.x","volume":"56","author":"P. H. Zingmark","year":"2003","unstructured":"P. H. Zingmark, M. Ekblom T. Odergren et al. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. Br. J. Clin. Pharmacol.\n                  56:173\u2013183 (2003).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"9093_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0009-9236(03)00049-3","volume":"73","author":"R. Miller","year":"2003","unstructured":"R. Miller, B. Frame B. Corrigan et al. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin. Pharmacol. Ther.\n                  73:491\u2013505 (2003).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9093_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2133\/dmpk.21.61","volume":"21","author":"T. Tanigawa","year":"2006","unstructured":"T. Tanigawa, R. Heinig, Y. Kuroki, and S. Higuchi. Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach. Drug Metab Pharmacokinet.\n                  21:61\u201369 (2006).","journal-title":"Drug Metab Pharmacokinet."},{"key":"9093_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/00007691-200112000-00007","volume":"23","author":"R. Hussein","year":"2001","unstructured":"R. Hussein, B. G. Charles, R. G. Morris, and R. L. Rasiah. Population pharmacokinetics of perhexiline from very sparse, routine monitoring data. Ther. Drug Monit.\n                  23:636\u2013643 (2001).","journal-title":"Ther. Drug Monit."},{"key":"9093_CR7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/AAC.42.7.1783","volume":"42","author":"B. Facca","year":"1998","unstructured":"B. Facca, B. Frame, and S. Triesenberg. Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients. Antimicrob. Agents Chemother.\n                  42:1783\u20131787 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9093_CR8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0091270003251853","volume":"43","author":"V. Piotrovsky","year":"2003","unstructured":"V. Piotrovsky, A. Van Peer, N. Van Osselaer, M. Armstrong, and J. Aerssens. Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations. J. Clin. Pharmacol.\n                  43:514\u2013523 (2003).","journal-title":"J. Clin. Pharmacol."},{"key":"9093_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2125.2003.01751.x","volume":"55","author":"N. Frey","year":"2003","unstructured":"N. Frey, C. Laveille, M. Paraire, M. Francillard, N. H. Holford, and R. Jochemsen. Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation. Br. J. Clin. Pharmacol.\n                  55:147\u2013157 (2003).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"9093_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1023\/B:JOPA.0000008157.26321.3c","volume":"30","author":"K. G. Kowalski","year":"2003","unstructured":"K. G. Kowalski, L. McFadyen, M. M. Hutmacher, B. Frame, and R. Miller. A two-part mixture model for longitudinal adverse event severity data. J. Pharmacokinet. Pharmacodyn.\n                  30:315\u2013336 (2003).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"9093_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jmri.20412","volume":"22","author":"M. E. Spilker","year":"2005","unstructured":"M. E. Spilker, K. Y. Seng A. A. Yao et al. Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability. J. Magn. Reson. Imaging.\n                  22:549\u2013558 (2005).","journal-title":"J. Magn. Reson. Imaging."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-009-9093-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9093-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-009-9093-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:47:44Z","timestamp":1559605664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-009-9093-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9093"],"URL":"https:\/\/doi.org\/10.1208\/s12248-009-9093-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}